HomeCompareBLKCF vs JNJ

BLKCF vs JNJ: Dividend Comparison 2026

BLKCF yields 20000000.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BLKCF wins by $4.875981653489057e+49M in total portfolio value
10 years
BLKCF
BLKCF
● Live price
20000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.875981653489057e+49M
Annual income
$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00
Full BLKCF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — BLKCF vs JNJ

📍 BLKCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBLKCFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BLKCF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BLKCF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BLKCF
Annual income on $10K today (after 15% tax)
$1,700,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$41,445,436,407,424,570,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, BLKCF beats the other by $41,445,436,407,424,570,000,000,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BLKCF + JNJ for your $10,000?

BLKCF: 50%JNJ: 50%
100% JNJ50/50100% BLKCF
Portfolio after 10yr
$2.4379908267445285e+49M
Annual income
$24,379,668,474,955,630,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
100.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BLKCF
No analyst data
Altman Z
-13.2
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BLKCF buys
0
JNJ buys
0
No recent congressional trades found for BLKCF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBLKCFJNJ
Forward yield20000000.00%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$4.875981653489057e+49M$20.0K
Annual income after 10y$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00$827.78
Total dividends collected$4.875978515990276e+49M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BLKCF vs JNJ ($10,000, DRIP)

YearBLKCF PortfolioBLKCF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$2,000,010,700$2,000,000,000.00$10,676$355.77+$2000.00MBLKCF
2$373,835,915,712,384$373,833,775,700,934.50$11,407$389.39+$373835915.70MBLKCF
3$65,304,953,364,964,970,000$65,304,553,360,535,160,000.00$12,198$426.53+$65304953364964.96MBLKCF
4$10,661,728,832,755,500,000,000,000$10,661,658,956,455,399,000,000,000.00$13,056$467.62+$10661728832755499008.00MBLKCF
5$1,626,767,783,781,495,000,000,000,000,000$1,626,756,375,731,643,800,000,000,000,000.00$13,987$513.12+$1.626767783781495e+24MBLKCF
6$231,974,330,054,625,100,000,000,000,000,000,000$231,972,589,413,096,470,000,000,000,000,000,000.00$14,998$563.56+$2.319743300546251e+29MBLKCF
7$30,915,106,403,922,057,000,000,000,000,000,000,000,000$30,914,858,191,388,900,000,000,000,000,000,000,000,000.00$16,098$619.52+$3.0915106403922057e+34MBLKCF
8$3,850,507,985,839,278,000,000,000,000,000,000,000,000,000,000$3,850,474,906,675,425,000,000,000,000,000,000,000,000,000,000.00$17,295$681.69+$3.8505079858392777e+39MBLKCF
9$448,210,261,035,314,200,000,000,000,000,000,000,000,000,000,000,000$448,206,140,991,769,400,000,000,000,000,000,000,000,000,000,000,000.00$18,599$750.82+$4.4821026103531426e+44MBLKCF
10$48,759,816,534,890,570,000,000,000,000,000,000,000,000,000,000,000,000,000$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00$20,022$827.78+$4.875981653489057e+49MBLKCF

BLKCF vs JNJ: Complete Analysis 2026

BLKCFStock

Global Gaming Technologies Corp., a gaming industry holding company, engages in the eSports, mobile and console games, and digital interactive entertainment businesses. It publishes mobile games; offers St. Noire, a cinematic board game; and provides Gamesquare, a video game API solution that enables electronic sports games, as well as operates eSports betting platform. The company was formerly known as Global Blockchain Technologies Corp. and changed its name to Global Gaming Technologies Corp. in February 2019. Global Gaming Technologies Corp. was incorporated in 2010 and is based in Vancouver, Canada.

Full BLKCF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this BLKCF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BLKCF vs SCHDBLKCF vs JEPIBLKCF vs OBLKCF vs KOBLKCF vs MAINBLKCF vs ABBVBLKCF vs MRKBLKCF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.